X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1000) 1000
Publication (120) 120
Book Review (16) 16
Book Chapter (14) 14
Newspaper Article (2) 2
Conference Proceeding (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (716) 716
index medicus (521) 521
residual symptoms (506) 506
psychiatry (459) 459
female (442) 442
male (435) 435
adult (357) 357
middle aged (334) 334
depression (296) 296
treatment outcome (228) 228
major depression (180) 180
aged (178) 178
remission (173) 173
clinical neurology (169) 169
mental depression (139) 139
care and treatment (138) 138
relapse (136) 136
psychology, clinical (135) 135
major depressive disorder (132) 132
antidepressive agents - therapeutic use (130) 130
depression, mental (128) 128
cognitive therapy (127) 127
neurosciences (118) 118
psychotherapy (117) 117
analysis (116) 116
adolescent (110) 110
depressive disorder, major - drug therapy (110) 110
recurrence (110) 110
depressive disorder, major - psychology (108) 108
antidepressants (105) 105
young adult (105) 105
psychiatric status rating scales (102) 102
disorder (100) 100
psychology (100) 100
comorbidity (96) 96
risk factors (93) 93
follow-up studies (90) 90
anxiety (85) 85
double-blind (84) 84
research (83) 83
prevalence (82) 82
pharmacology & pharmacy (81) 81
depressive disorder, major - diagnosis (80) 80
depressive disorder, major - therapy (80) 80
follow-up (80) 80
symptoms (80) 80
severity of illness index (77) 77
quality of life (76) 76
surveys and questionnaires (71) 71
article (70) 70
medicine & public health (69) 69
insomnia (68) 68
therapy (68) 68
patients (67) 67
recovery (67) 67
bipolar disorder (64) 64
sleep (64) 64
combined modality therapy (63) 63
secondary prevention (60) 60
cognitive-behavioral therapy (59) 59
quality-of-life (59) 59
residual depression (58) 58
randomized controlled-trial (57) 57
studies (57) 57
cognitive-behavioral treatment (56) 56
prevention (56) 56
pharmacotherapy (54) 54
rating-scale (54) 54
recurrent depression (53) 53
star-asterisk-d (53) 53
time factors (52) 52
depressive disorder - psychology (51) 51
medical research (51) 51
prognosis (51) 51
prospective studies (51) 51
drug therapy (50) 50
remission induction (49) 49
schizophrenia (49) 49
aged, 80 and over (47) 47
clinical trials (47) 47
efficacy (46) 46
mental disorders (45) 45
cognitive ability (44) 44
cognitive behavioral therapy (44) 44
metaanalysis (44) 44
mortality (44) 44
cognitive therapy - methods (43) 43
medicine, experimental (43) 43
primary-care (43) 43
children (42) 42
depression - psychology (42) 42
double-blind method (42) 42
depressive disorder - drug therapy (40) 40
fluoxetine (40) 40
neurology (40) 40
pain (39) 39
scale (39) 39
cross-sectional studies (38) 38
depressive disorder - therapy (38) 38
psychometrics (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (974) 974
French (20) 20
German (8) 8
Spanish (7) 7
Italian (5) 5
Turkish (3) 3
Russian (2) 2
Dutch (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 12/2006, Volume 45, Issue 12, pp. 1404 - 1411
Journal Article
Journal Article
CNS Spectrums, ISSN 1092-8529, 06/2013, Volume 21, Issue 1, pp. 43 - 52
Journal Article
Psychological Medicine, ISSN 0033-2917, 01/2010, Volume 40, Issue 1, pp. 41 - 50
Journal Article
Psychosomatic Medicine, ISSN 0033-3174, 05/2018, Volume 80, Issue 4, pp. 385 - 392
Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 02/2008, Volume 69, Issue 2, pp. 246 - 258
Objective: Recent data indicate that more than 65% of patients with major depressive disorder (MDD) fail to achieve remission. This article reviews research on... 
STAR-ASTERISK-D | ANTIDEPRESSANT-INDUCED REMISSION | CORTICOTROPIN-RELEASING-FACTOR | POSITRON-EMISSION-TOMOGRAPHY | CYP2D6 GENE DUPLICATION | PSYCHIATRY | RESIDUAL SYMPTOMS | MAJOR DEPRESSION | PSYCHOLOGY, CLINICAL | SEROTONIN(1A) RECEPTOR-BINDING | BLOOD-BRAIN-BARRIER | P-GLYCOPROTEIN | Humans | Neurotransmitter Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - therapeutic use | Neurotransmitter Uptake Inhibitors - pharmacology | Cognition Disorders - metabolism | Depressive Disorder - drug therapy | Antidepressive Agents, Second-Generation - therapeutic use | Depression - genetics | Depression - drug therapy | Sleep Wake Disorders - metabolism | Depression - metabolism | Antidepressive Agents - pharmacology | Anxiety - metabolism | Dopamine - metabolism | Depressive Disorder - genetics | Hypothalamo-Hypophyseal System - drug effects | Adrenergic Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - pharmacology | Pituitary-Adrenal System - drug effects | Pituitary-Adrenal System - metabolism | Serotonin Uptake Inhibitors - therapeutic use | Antidepressive Agents, Second-Generation - pharmacology | Depressive Disorder - metabolism | Hypothalamo-Hypophyseal System - metabolism | Antidepressive Agents - therapeutic use | Algorithms | Norepinephrine - metabolism | Serotonin - metabolism | Depression - psychology | Adrenergic Uptake Inhibitors - pharmacology | Decision Trees | Depressive Disorder - psychology | Serotonin Uptake Inhibitors - pharmacology
Journal Article
Dialogues in Clinical Neuroscience, ISSN 1294-8322, 2008, Volume 10, Issue 4, pp. 431 - 437
Partial remission from depression, with residual symptoms, is an important problem in depression. This paper reviews the frequency and features of this... 
Depression | Remission | Residual symptom | Relapse | Antidepressive Agents - therapeutic use | Recurrence | Humans | Depressive Disorder - drug therapy | Depressive Disorder - psychology | Social Adjustment | Bipolar Disorder - drug therapy | Bipolar Disorder - psychology | depression | Clinical Research | relapse | residual symptom | remission
Journal Article
Psychosomatic Medicine, ISSN 0033-3174, 03/2018, Volume 80, Issue 4, pp. 1 - 392
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2012, Volume 51, Issue 4, pp. 404 - 411
Objective To identify symptom dimensions of depression that predict recovery among selective serotonin reuptake inhibitor (SSRI) treatment–resistant... 
Pediatrics | Psychiatry | clinical trial | adolescence | cognitive-behavioral therapy | depression | treatment-resistant | ADOLESCENT DEPRESSION | COST-EFFECTIVENESS | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | ACUTE ANTIDEPRESSANT TREATMENT | VENLAFAXINE | MODERATORS | RESIDUAL SYMPTOMS | TREATMENT RESPONSE | PEDIATRICS | BRAIN | REMISSION | Neurological Impairments | Brain | Drug Therapy | Prediction | Youth | Identification | Time | Computer Assisted Instruction | Depression (Psychology) | Outcomes of Treatment | Adolescents | Rating Scales | Symptoms (Individual Disorders) | Antidepressive Agents, Second-Generation - adverse effects | Cyclohexanols - adverse effects | Depressive Disorder, Treatment-Resistant - diagnosis | Humans | Psychotherapy | Male | Antidepressive Agents, Second-Generation - therapeutic use | Anhedonia - drug effects | Female | Drug Resistance | Depressive Disorder, Major - drug therapy | Depressive Disorder, Treatment-Resistant - psychology | Affect - drug effects | Double-Blind Method | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Psychometrics | Combined Modality Therapy | Depressive Disorder, Treatment-Resistant - drug therapy | Depressive Disorder, Major - psychology | Venlafaxine Hydrochloride | Personality Assessment - statistics & numerical data | Adolescent | Cyclohexanols - therapeutic use | Cognitive Therapy | Depressive Disorder, Major - diagnosis | Drug Substitution | Longitudinal Studies | Anhedonia | Care and treatment | Prognosis
Journal Article
Australian & New Zealand Journal of Psychiatry, ISSN 0004-8674, 10/2018, Volume 52, Issue 10, pp. 994 - 1002
Objective: Activation encompasses energy and activity and is a central feature of bipolar disorder. However, the impact of activation on treatment response of... 
treatment | Bipolar disorder | depression | treatment outcome | energy | PSYCHIATRY | MIXED FEATURES | POST HOC ANALYSIS | ANTIDEPRESSANT TREATMENT | PSYCHOMOTOR ACTIVITY | RESTING ENERGY-EXPENDITURE | TREATMENT ENHANCEMENT PROGRAM | RESIDUAL SYMPTOMS | UNIPOLAR DEPRESSION | DISORDER STEP-BD | OUTCOMES
Journal Article